title: Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
abstract: Zidovudine (AZT) is not the only drug with some effect on HIV. New agents and better-directed use of established agents can delay progression of the disease and prevent the onset of symptoms for some time.
authors.affiliation: AIDS Pathogenesis Research Unit, Macfarlane Burnet Centre for Medical Research, Melbourne, VIC Australia.
authors.forename: S
authors.initials: S
authors.lastname: Crowe
authors.forename: D A
authors.initials: DA
authors.lastname: Cooper
authors.forename: D E
authors.initials: DE
authors.lastname: Chambers
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016049:Didanosine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D015337:Multicenter Studies as Topic; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine